Related Experiment Video

Updated: Aug 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Perinatal effects of prenatal drug exposure. Neonatal aspects

C R Bauer1

  • 1Department of Pediatrics, Obstetrics-Gynecology, University of Miami School of Medicine, Florida, USA. cbauer@peds.med.miami.edu

Clinics in Perinatology
|April 24, 1999
PubMed

Insights

Substance exposure in children, when combined with other risk factors, complicates failure to thrive assessments. However, drug exposure is a preventable form of child abuse, with education as a key intervention strategy.

Area of Science:

  • Pediatrics
  • Child Development
  • Public Health

Background:

  • Child failure to thrive (FTT) is often multifactorial, influenced by socioeconomic status, nutrition, stimulation, and exposure to abuse or violence.
  • Intertwined risk factors make it challenging to isolate the specific impact of substance exposure on child development.
  • Societal issues beyond individual control often exacerbate FTT, but substance exposure is an exception.

Purpose of the Study:

  • To highlight the preventable nature of drug exposure as a form of child abuse.
  • To emphasize the role of information and education in intervening in cases of child substance exposure.
  • To differentiate substance exposure from other societal risk factors impacting child development.

Main Methods:

  • This study is a conceptual analysis and literature review.
  • It synthesizes existing research on child failure to thrive and substance exposure.
  • It focuses on the etiology and prevention of child maltreatment related to drug exposure.

Main Results:

  • Isolating the impact of substance exposure is difficult due to confounding factors like poverty and neglect.
  • Unlike many societal factors, maternal substance abuse and environmental contamination are potentially addressable by individuals.
  • Deliberate drug exposure constitutes child abuse and is preventable.

Conclusions:

  • Information and education are critical for effective intervention against child substance exposure.
  • Preventing deliberate drug exposure is a crucial step in addressing child abuse.
  • Addressing substance exposure directly offers a tangible intervention point for improving child outcomes.

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...